| Heading: |
Coronavirus: Vaccination |
| Question ID: |
1745225 |
| UIN: |
16448 |
| House: |
Commons |
| Date tabled: |
2024-11-27 |
| Asking Member ID: |
242 |
| Asking Member display name: |
Sir Christopher Chope
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Sir Christopher Chope
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, whether any of the vials of (a) Pfizer and (b) Moderna covid-19 vaccines supplied to patients in the United Kingdom contained (i) variable and (ii) excessive levels of residual plasmid DNA. |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2024-12-02 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
1506 |
| Answering Member display name: |
Andrew Gwynne
|
| Answering Member handle: |
GwynneMP
|
| Answering Member Twitter reference: |
@GwynneMP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
All batches of the Pfizer and Moderna COVID-19 vaccines released in the United Kingdom to date have passed their release specifications for DNA levels. The specifications are set in line with their respective controlled manufacturing process and in accord... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |